- $6.61m
- $7.51m
- $1.59m
- 29
- 56
- 69
- 50
Annual balance sheet for Vycor Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.046 | 0.091 | 0.037 | 0.057 | 0.106 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.159 | 0.126 | 0.156 | 0.215 | 0.245 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.464 | 0.487 | 0.518 | 0.584 | 0.696 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.505 | 0.442 | 0.336 | 0.402 | 0.296 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.987 | 0.935 | 0.86 | 0.992 | 0.998 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.74 | 3.15 | 3.65 | 4.07 | 4.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.97 | 3.33 | 3.8 | 4.32 | 4.69 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -1.98 | -2.4 | -2.94 | -3.33 | -3.69 |
| Total Liabilities & Shareholders' Equity | 0.987 | 0.935 | 0.86 | 0.992 | 0.998 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |